Status:
WITHDRAWN
Reverse Axillary Mapping in Breast Radiation Treatment Planning
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Conditions:
Breast Cancer
Lymphedema
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this prospective study is to investigate the role of axillary reverse mapping (ARM) in radiation therapy planning of patients with breast cancer. Lymphedema is a common side effect after s...
Eligibility Criteria
Inclusion
- De novo presentation of post-operative (lumpectomy or mastectomy) female breast cancer patients to receive radiation to the whole breast or chest wall and the regional nodes. Patients who have received a sentinel lymph node (SLN) biopsy or an axillary lymph node dissection (ALND) will be eligible.
- Greater than or equal to 18 years of age (no upper age limit).
- Informed consent obtained.
Exclusion
- Prisoners.
- Patients with metastatic breast cancer.
- Documented allergy to iodinated contrast
- Prior breast or axillary surgeries or radiation.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04292860
Start Date
May 1 2021
End Date
January 1 2027
Last Update
May 27 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.